science
Blood Test Predicts Alzheimer's Disease in Large Cohort
A blood test measuring p-tau217 levels showed strong performance in identifying Alzheimer's disease among participants with an average age of 61. The findings appear in a new issue of a medical journal.
May 28, 6:38 PM·1m read1 source
ER
neurosciencenews.comAudio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.
A blood test measuring p-tau217 protein levels identified Alzheimer's disease in a large group of participants whose average age was 61. The results replicate earlier studies and appear on the cover of the latest issue of the journal. Researchers presented the data as further evidence that the test can detect disease-related changes in a younger population than previously studied.
No individual researchers or institutions were named in the report.
Transparency
How sources framed this
ER
ER
Single source — no framing comparison available.
CorroborationModerate · 1 source
